Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Home OCT-Guided Treatment Versus Treat and Extend for the Management of Neovascular AMD

NCT05904028 is registered in ClinicalTrials.gov with Jaeb Center for Health Research as lead sponsor.

NCT NCT05904028
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05904028 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Home OCT-Guided Treatment Versus Treat and Extend for the Management of Neovascular AMD
Lead sponsor
Jaeb Center for Health Research
Phase
Phase 3
Overall status
Active, not recruiting
Start date
November 9, 2023
Completion date
July 30, 2027
Enrollment
603 (actual)
Sites
64

Conditions

As the registry lists them; a condition with its own page is linked.

neovascular age-related macular degeneration